Connect with us

Technology

COSRX Celebrates the Return of The 6 Peptide Skin Booster Serum – A Derm-Favorite Now Back in Stock at Ulta

Published

on

LOS ANGELES, Feb. 16, 2024 /PRNewswire/ — COSRX, the beloved beauty brand known for its derm-favourite skincare solutions, is delighted to announce the return of the COSRX The 6 Peptide Skin Booster Serum at Ulta.

Following an extraordinary launch that saw COSRX’s The 6 Peptide Skin Booster Serum completely sell out at Ulta within a mere 9 days of its launch, the highly coveted skincare product is now back in stock to meet overwhelming demand.

Effective Yet Accessible Skincare

The exceptional popularity of The 6 Peptide Skin Booster Serum can be attributed to its unique blend of six peptides which works wonders in addressing various skin concerns, making it the go-to solution for anyone seeking perfect skin. While peptides are traditionally associated with luxury skincare, this serum has been carefully designed and formulated for ultimate comfort and ease of use, all at an affordable price point for everyone and anyone to enjoy.

Housed in a jumbo-sized pump bottle, the peptide serum is ideal for generous, daily use. Its lightweight, water-based formula ensures quick absorption, leaving behind intense hydration all without that greasy feeling for quick effortless layering with other skincare products. Simply add it to any skincare routine, either by layering it several times or incorporating it as the first step to enhance results.

The Ultimate Skin Booster

COSRX recommends incorporating The 6 Peptide Skin Booster Serum as the first step of one’s skincare routine. Though it can be used as a standalone item, combining it with other skincare products will ensure synergistic action that boosts efficacy and ensures greater results from any skincare routine. It pairs perfectly with various COSRX products, such as The Retinol 0.1 Cream/The Retinol 0.5 Oil for wrinkles and firmness, The Niacinamide 15 Serum for pores and excess sebum, The Hyaluronic Acid 3 Serum for hydration and plumping the skin, and The Vitamin C 23 Serum/The Vitamin C 13 Serum for brightening and hyperpigmentation.

“We are delighted to bring back The 6 Peptide Skin Booster Serum to Ulta after its remarkable success,” said a spokesperson for COSRX. “The demand for this product speaks to its efficacy and the growing interest in skincare solutions that deliver visible results. We are proud to offer a product that combines dermatologist-recommended ingredients with accessibility, allowing more individuals to achieve their skincare goals.”

For those who may have missed out on the initial launch, now is the perfect opportunity to discover why COSRX’s The 6 Peptide Skin Booster Serum has become a must-have item. COSRX remains committed to innovation and customer satisfaction, and the restock of The 6 Peptide Skin Booster Serum at Ulta reflects the brand’s dedication to meeting the evolving needs of skincare enthusiasts. For more information or to make a purchase, visit Ulta’s online store.

About COSRX:

With its powerful yet affordable skincare solutions, COSRX has quickly become one of America’s favorite skincare brands. Using a minimal number of highly effective natural extracts in concentrated doses, COSRX products deliver visible results by treating skin with only the essentials it needs and nothing it doesn’t. Find its best-selling skincare solutions at retailers nationwide, including Amazon, Ulta, Revolve, and Dermstore.

Instagram: https://www.instagram.com/cosrxTikTok: https://www.tiktok.com/@cosrx_officialCOSRX Official Website: https://www.cosrx.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/cosrx-celebrates-the-return-of-the-6-peptide-skin-booster-serum—a-derm-favorite-now-back-in-stock-at-ulta-302063851.html

SOURCE COSRX

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

TriNetX’s Founding CEO Announces Plans to Step Down

Published

on

By

After 11 Years, Gadi Lachman to Conclude Operating Role, Remain on TriNetX’s Board

CAMBRIDGE, Mass., Jan. 9, 2025 /PRNewswire/ — TriNetX, the largest global source of real-world data, today announced that Gadi Lachman, the Company’s Founder, President and CEO, will step down from his operating role on March 31, 2025. Gadi founded TriNetX in 2014 and has served as President and CEO in the succeeding 11 years. Gadi will continue to serve on TriNetX’s Board of Directors and will be an Advisor to Carlyle, TriNetX’s majority investor.

“It has been an honor to build TriNetX and be part of such an outstanding team. I want to thank TriNetX’s employees, customers, and shareholders for the support they have shown me. With the talent and passion of our people I am immensely confident in TriNetX’s continued success,” said Lachman. “Together, we have built the largest global platform for clinical research, with data from over 25 countries and tens of millions of queries a month. Our solutions are moving clinical research to a whole different level and saving lives on a massive scale, across all therapeutic areas.”

During the transition period, Jeff Margolis, a current TriNetX Director, will serve as Executive Chairman to ensure continuity in leadership and governance while a CEO search is conducted.

Margolis said, “I have had the distinct privilege of serving on the Board alongside Gadi and partnering with him for 11 years. On behalf of the Board, we thank Gadi for shaping and leading TriNetX to become the world’s top ecosystem of real-world data and real-world evidence serving life sciences and the broader healthcare industry. I look forward to working with him and the rest of the Board over the next months to execute a successful transition of leadership.”

Joe Bress, Partner and Global Co-Head of Healthcare for Carlyle, TriNetX’s lead investor, added, “We have been thrilled to partner with Gadi since our initial investment in TriNetX over four years ago. Thanks to his disciplined leadership, TriNetX is one of the few companies that has sustained profitability even during periods of high growth. Gadi has built the company up to an exciting point, paving the way for a new leader to take the business into its next chapter of growth and success.”

Through this leadership transition, TriNetX remains steadfast in its mission to advance global healthcare through the power of real-world data. The Board, leadership team, and employees are united in their commitment to driving continued innovation and delivering success for customers and partners, all while building on Gadi’s exceptional legacy.

About TriNetX, LLC

TriNetX is a global network of healthcare organizations and life sciences companies dedicated to advancing real-world research and expediting the development of new therapies. Through its self-service, HIPAA-, GDPR-, and LGPD-compliant platform of federated deidentified and anonymous electronic health record datasets and consulting partnerships, TriNetX empowers its global community to improve clinical trial protocol design, streamline trial operations, refine safety signals, and enrich real-world evidence generation. For more information, please visit TriNetX at www.trinetx.com or follow TriNetX on LinkedIn.

Media Contact
TriNetX
Michelle Fleming, Chief Marketing Officer
Email: Michelle.Fleming@TriNetX.com

Logo – https://mma.prnewswire.com/media/542641/TriNetX_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/trinetxs-founding-ceo-announces-plans-to-step-down-302347367.html

Continue Reading

Technology

Stellus Private Credit BDC Announces $0.36 First Quarter 2025 Regular Dividend, Payable Monthly in Increments of $0.12 in January, February, and March 2025

Published

on

By

HOUSTON, Jan. 9, 2025 /PRNewswire/ — Stellus Private Credit BDC (“the Company”) announced that its Board of Trustees has declared a monthly dividend of $0.12 for each of January, February, and March, totaling $0.36 per share in the aggregate for the first quarter of 2025. The regular dividend of $0.36 per share will be paid to shareholders of record in January, February, and March 2025.

Summary of First Quarter 2025 Regular Monthly Dividends

Declared

Record Date

Payment Date

Amount per Share

1/9/2025

1/10/2025

1/31/2025

$0.12

1/9/2025

2/3/2025

2/28/2025

$0.12

1/9/2025

3/3/2025

3/31/2025

$0.12

About Stellus Private Credit BDC

The Company is an externally-managed, closed-end, non-diversified investment management company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended. The Company’s investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation by investing primarily in private middle-market companies (typically those with $5.0 million to $50.0 million of EBITDA (earnings before interest, taxes, depreciation and amortization)) through first lien (including unitranche) loans, second lien loans and unsecured debt financing, with corresponding equity co-investments. The Company’s investment activities are managed by its investment adviser, Stellus Private BDC Advisor, LLC.

Forward-Looking Statements

Statements included herein may contain “forward-looking statements” which relate to future performance or financial condition. Statements other than statements of historical facts included in this press release, including statements about COVID-19 and its impacts, may constitute forward-looking statements and are not guarantees of future performance or results and involve a number of assumptions, risks and uncertainties, which change over time. Actual results may differ materially from those anticipated in any forward-looking statements as a result of a number of factors, including those described from time to time in filings by the Company with the Securities and Exchange Commission including the final prospectus that will be filed with the Securities and Exchange Commission. The Company undertakes no duty to update any forward-looking statement made herein. All forward-looking statements speak only as of the date of this press release.

Contacts
Stellus Private Credit BDC
W. Todd Huskinson, Chief Financial Officer
(713) 292-5414
thuskinson@stelluscapital.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/stellus-private-credit-bdc-announces-0-36-first-quarter-2025-regular-dividend-payable-monthly-in-increments-of-0-12-in-january-february-and-march-2025–302347311.html

SOURCE Stellus Private Credit BDC

Continue Reading

Technology

MongoDB, Inc. to Present at the 27th Annual Needham Growth Conference

Published

on

By

NEW YORK, Jan. 9, 2025 /PRNewswire/ — MongoDB, Inc. (NASDAQ: MDB) today announced that Chief Operating Officer and Chief Financial Officer, Michael Gordon, and Senior Vice President of Finance, Serge Tanjga, will present virtually at the 27th Annual Needham Growth Conference.

The MongoDB presentation is scheduled for Thursday, January 16, 2025, at 3:45 p.m. Eastern Time. A live webcast of the presentation will be available on the Events page of the MongoDB investor relations website at https://investors.mongodb.com/news-events/events. A replay of the webcast will also be available for a limited time.

About MongoDB
Headquartered in New York, MongoDB’s mission is to empower innovators to create, transform, and disrupt industries by unleashing the power of software and data. Built by developers, for developers, MongoDB’s developer data platform is a database with an integrated set of related services that allow development teams to address the growing requirements for today’s wide variety of modern applications, all in a unified and consistent user experience. MongoDB has tens of thousands of customers in over 100 countries. The MongoDB database platform has been downloaded hundreds of millions of times since 2007, and there have been millions of builders trained through MongoDB University courses. To learn more, visit mongodb.com.

Investor Relations
Brian Denyeau
ICR for MongoDB
646-277-1251
ir@mongodb.com

Media Relations
MongoDB PR
press@mongodb.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/mongodb-inc-to-present-at-the-27th-annual-needham-growth-conference-302347475.html

SOURCE MongoDB, Inc.

Continue Reading

Trending